Rebif

EMD Serono, Inc.🇺🇸 United States

FDA Page

Effective Date: Aug 4, 2023
Approval ID: c6fcb5d2-8fcd-44fa-a838-b84ee5f44f0f
Products: 6 registered
Version: 26

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use REBIF safely and effectively. See full prescribing information for REBIF. REBIF (interferon beta-1a), for subcutaneous injection Initial U.S. Approval: 1996

Quick Stats

Total Products6

Labelers2

Label Sections30

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.